Page last updated: 2024-08-24

tocoretinate and Vitiligo

tocoretinate has been researched along with Vitiligo in 1 studies

*Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujimoto, S; Kikuchi, K; Komine, M; Ohmatsu, H; Ohtsuki, M; Tada, Y; Tamaki, K; Wu, CS; Yu, HS1

Other Studies

1 other study(ies) available for tocoretinate and Vitiligo

ArticleYear
Reagents inducing epidermal proliferation also induce pigmentation: induction of keratinocyte proliferation as a novel strategy for the treatment of vitiligo.
    Journal of dermatological science, 2013, Volume: 72, Issue:1

    Topics: Administration, Topical; Animals; Cell Proliferation; Drug Combinations; Guinea Pigs; Humans; Indicators and Reagents; Keratinocytes; Male; Skin Pigmentation; Tretinoin; Vitamin E; Vitiligo

2013